Artelo Biosciences
$1.139876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.86%) As of 2:47 PM UTC today
Why Robinhood?
You can buy or sell ARTL and other stocks, options, and ETFs commission-free!
About ARTL
Artelo Biosciences, Inc. Common Stock, also called Artelo Biosciences, is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system. The company was founded by James Manley on May 2, 2011 and is headquartered in San Diego, CA. The listed name for ARTL is Artelo Biosciences, Inc. Common Stock.
CEO
Gregory D. Gorgas
Employees
3
Headquarters
San Diego, California
Founded
2011
Market Cap
15.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.94M
High Today
$1.14
Low Today
$1.11
Open Price
$1.13
Volume
208.10K
52 Week High
$4.42
52 Week Low
$0.451
Collections
ARTL Earnings
-$0.42
-$0.28
-$0.14
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.38 per share
Actual
-$0.14 per share